Athersys and Healios K.K. Announce Advancement of Their MultiStem Commercial Partnership

CLEVELAND & TOKYO–(BUSINESS WIRE)–Athersys, Inc. (NASDAQ: ATHX) and HEALIOS K.K. (Healios) (TSE Mothers: 4593) jointly announced today an expansion and deepening of their partnership to optimize and better align the collaboration structure to drive therapeutic…

Click here to view the original article.